NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.14% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.05% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.88% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.87% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.86% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.80% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.60% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.51% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.51% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.48% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.44% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.44% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.39% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.38% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.25% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.19% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.19% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.15% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.06% |